Impact of adherence to ibrutinib on clinical outcomes in real-world patients with chronic lymphocytic leukemia. Collins J 4th, Stump SE, Heiling H, Muir M, et al. Leuk Lymphoma 2022 Mar 6:1-8. doi: 10.1080/10428194.2022.2045597.

Read + Share

Amedeo Smart

Independent Medical Education

Collins J 4th, Stump SE, Heiling H, Muir M, et al. Impact of adherence to ibrutinib on clinical outcomes in real-world patients with chronic lymphocytic leukemia. Leuk Lymphoma 2022 Mar 6:1-8. doi: 10.1080/10428194.2022.2045597.
PMID: 35249442